Related Experiment Video
Updated: Aug 4, 2026
08:02
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Mineralocorticoid replacement in Addison's disease
Clinical Endocrinology
|May 1, 1979
Summary
Fludrocortisone dosage in Addison's disease requires careful monitoring. Plasma potassium levels, not plasma renin activity, effectively indicated mineralocorticoid overdosage in this study.
Area of Science:
- Endocrinology
- Mineralocorticoid Replacement Therapy
- Addison's Disease Management
Background:
- Addison's disease necessitates mineralocorticoid and glucocorticoid replacement therapy.
- Optimizing fludrocortisone dosage is crucial for managing electrolyte balance and blood pressure.
- Assessing adequate mineralocorticoid replacement can be challenging.
Purpose of the Study:
- To evaluate the efficacy of different fludrocortisone doses in patients with treated Addison's disease.
- To determine the utility of plasma renin activity (PRA) in assessing mineralocorticoid replacement adequacy.
- To identify reliable indicators of both inadequate and excessive fludrocortisone therapy.
Main Methods:
- Eight patients with treated Addison's disease received varying fludrocortisone doses with stable glucocorticoid intake.
- Key parameters including plasma renin activity (PRA), blood pressure, pulse rate, and plasma potassium/urea were monitored over 2-week intervals.
- Data analysis focused on correlating fludrocortisone dosage with physiological and biochemical markers.
Main Results:
- Two patients showed inadequate mineralocorticoid replacement based on PRA.
- Four patients maintained normal PRA even after fludrocortisone discontinuation, suggesting unnecessary therapy.
- Low plasma potassium concentrations indicated asymptomatic fludrocortisone overdosage, a finding not reliably detected by PRA.
Conclusions:
- Plasma renin activity (PRA) may not be a sensitive indicator for distinguishing adequate from excessive mineralocorticoid replacement in Addison's disease.
- Plasma potassium concentration is a more reliable marker for detecting asymptomatic fludrocortisone overdosage.
- Individualized fludrocortisone dosing and monitoring of electrolytes are essential for optimal Addison's disease management.
Related Concept Videos
01:31Hormones of the Adrenal Glands
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...